HomeTTI • CVE
add
Thiogenesis Therapeutics Corp
Nakaraang pagsara
$0.62
Sakop ng araw
$0.60 - $0.63
Sakop ng taon
$0.51 - $0.88
Market cap
31.10M CAD
Average na Volume
25.00K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 2.39M | 253.27% |
Net na kita | -2.38M | -262.94% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 3.50M | -15.55% |
Kabuuang asset | 3.63M | -14.77% |
Kabuuang sagutin | 1.47M | 1,289.66% |
Kabuuang equity | 2.15M | — |
Natitirang share | 51.84M | — |
Presyo para makapag-book | 15.50 | — |
Return on assets | -215.11% | — |
Return on capital | -458.68% | — |
Cash Flow
Net change in cash
| (CAD) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -2.38M | -262.94% |
Cash mula sa mga operasyon | -2.12M | -154.41% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 3.81M | 54,351.57% |
Net change in cash | 1.66M | 301.49% |
Malayang cash flow | -1.24M | -105.53% |
Tungkol
Itinatag
2018
Headquarters
Website
